ATE249826T1 - Isobutenyl-substituierte taxane und deren pharmazeutische zusammensetzungen - Google Patents
Isobutenyl-substituierte taxane und deren pharmazeutische zusammensetzungenInfo
- Publication number
- ATE249826T1 ATE249826T1 AT94902223T AT94902223T ATE249826T1 AT E249826 T1 ATE249826 T1 AT E249826T1 AT 94902223 T AT94902223 T AT 94902223T AT 94902223 T AT94902223 T AT 94902223T AT E249826 T1 ATE249826 T1 AT E249826T1
- Authority
- AT
- Austria
- Prior art keywords
- isobutenyl
- pharmaceutical compositions
- substituted taxanes
- substituted
- taxanes
- Prior art date
Links
- 229940123237 Taxane Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 abstract 1
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/22—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from lactams, cyclic ketones or cyclic oximes, e.g. by reactions involving Beckmann rearrangement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/81—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/82—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/87—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/60—Ring systems containing bridged rings containing three rings containing at least one ring with less than six members
- C07C2603/62—Ring systems containing bridged rings containing three rings containing at least one ring with less than six members containing three- or four-membered rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/975,705 US5284864A (en) | 1991-09-23 | 1992-11-13 | Butenyl substituted taxanes and pharmaceutical compositions containing them |
| US08/005,229 US5338872A (en) | 1993-01-15 | 1993-01-15 | Process for the preparation of 10-desacetoxybaccatin III and 10-desacetoxytaxol and derivatives thereof |
| US08/010,798 US5399726A (en) | 1993-01-29 | 1993-01-29 | Process for the preparation of baccatin III analogs bearing new C2 and C4 functional groups |
| US08/026,978 US5990325A (en) | 1993-03-05 | 1993-03-05 | Process for the preparation of 9-desoxotaxol, 9-desoxobaccatin III and analogs thereof |
| US08/034,247 US5430160A (en) | 1991-09-23 | 1993-03-22 | Preparation of substituted isoserine esters using β-lactams and metal or ammonium alkoxides |
| US9471993A | 1993-07-20 | 1993-07-20 | |
| PCT/US1993/010813 WO1994010996A1 (en) | 1992-11-13 | 1993-11-01 | Butenyl-substituted taxanes and composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE249826T1 true ATE249826T1 (de) | 2003-10-15 |
Family
ID=27555508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94902223T ATE249826T1 (de) | 1992-11-13 | 1993-11-01 | Isobutenyl-substituierte taxane und deren pharmazeutische zusammensetzungen |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0668762B1 (de) |
| JP (2) | JPH08503218A (de) |
| CN (2) | CN1065240C (de) |
| AT (1) | ATE249826T1 (de) |
| CA (1) | CA2147984C (de) |
| DE (1) | DE69333208T2 (de) |
| DK (1) | DK0668762T3 (de) |
| ES (1) | ES2206465T3 (de) |
| IL (1) | IL107554A (de) |
| PT (1) | PT668762E (de) |
| WO (1) | WO1994010996A1 (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5710287A (en) | 1991-09-23 | 1998-01-20 | Florida State University | Taxanes having an amino substituted side-chain and pharmaceutical compositions containing them |
| US5405972A (en) * | 1993-07-20 | 1995-04-11 | Florida State University | Synthetic process for the preparation of taxol and other tricyclic and tetracyclic taxanes |
| FR2712289B1 (fr) * | 1993-11-08 | 1996-01-05 | Rhone Poulenc Rorer Sa | Nouveaux dérivés de taxicine, leur préparation et les compositions pharmaceutiques qui les contiennent. |
| GB9405400D0 (en) * | 1994-03-18 | 1994-05-04 | Erba Carlo Spa | Taxane derivatives |
| US6500858B2 (en) | 1994-10-28 | 2002-12-31 | The Research Foundation Of The State University Of New York | Taxoid anti-tumor agents and pharmaceutical compositions thereof |
| JPH10508022A (ja) * | 1994-10-28 | 1998-08-04 | ザ リサーチ ファウンデーション オブ ステート ユニバーシティ オブ ニューヨーク | タキソイド誘導体、それらの製造、およびそれらの抗腫瘍薬としての使用 |
| US6458976B1 (en) | 1994-10-28 | 2002-10-01 | The Research Foundation Of State University Of New York | Taxoid anti-tumor agents, pharmaceutical compositions, and treatment methods |
| EP1391459A1 (de) * | 1999-08-11 | 2004-02-25 | Bristol-Myers Squibb Company | Verfahren zur Herstellung eines Paclitaxel C-4 Methyl-Carbonat Analogen und Zwischenprodukte |
| EP1664033B1 (de) | 2003-09-25 | 2007-11-07 | Tapestry Pharmaceuticals, Inc. | 9,10-alpha,alpha-oh-taxananaloga und verfahren zu deren herstellung |
| SI1664033T1 (sl) * | 2003-09-25 | 2008-04-30 | Tapestry Pharmaceuticals Inc | Analogi 9,10-alfa,alfa-oh-taksana in postopki za proizvodnjo le-teh |
| WO2008106621A1 (en) | 2007-02-28 | 2008-09-04 | Tapestry Pharmaceuticals, Inc | Taxane analogs for the treatment of brain cancer |
| US11786504B2 (en) | 2006-09-28 | 2023-10-17 | Tapestry Pharmaceuticals, Inc. | Taxane analogs for the treatment of brain cancer |
| US11873308B2 (en) | 2006-11-06 | 2024-01-16 | Tapestry Pharmaceuticals, Inc. | Biologically active taxane analogs and methods of treatment by oral administration |
| WO2008121476A1 (en) | 2007-03-28 | 2008-10-09 | Tapestry Pharmaceuticals, Inc. | Biologically active taxane analogs and methods of treatment by oral administration |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4680391A (en) * | 1983-12-01 | 1987-07-14 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| US5175315A (en) * | 1989-05-31 | 1992-12-29 | Florida State University | Method for preparation of taxol using β-lactam |
-
1993
- 1993-11-01 WO PCT/US1993/010813 patent/WO1994010996A1/en active IP Right Grant
- 1993-11-01 PT PT94902223T patent/PT668762E/pt unknown
- 1993-11-01 CA CA002147984A patent/CA2147984C/en not_active Expired - Fee Related
- 1993-11-01 JP JP6512298A patent/JPH08503218A/ja active Pending
- 1993-11-01 EP EP94902223A patent/EP0668762B1/de not_active Expired - Lifetime
- 1993-11-01 AT AT94902223T patent/ATE249826T1/de not_active IP Right Cessation
- 1993-11-01 ES ES94902223T patent/ES2206465T3/es not_active Expired - Lifetime
- 1993-11-01 DE DE69333208T patent/DE69333208T2/de not_active Expired - Fee Related
- 1993-11-01 DK DK94902223T patent/DK0668762T3/da active
- 1993-11-10 IL IL10755493A patent/IL107554A/xx not_active IP Right Cessation
- 1993-11-13 CN CN93112764A patent/CN1065240C/zh not_active Expired - Fee Related
-
1999
- 1999-08-18 CN CNB991180607A patent/CN1205184C/zh not_active Expired - Fee Related
-
2006
- 2006-07-06 JP JP2006186450A patent/JP2006257108A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2147984A1 (en) | 1994-05-26 |
| CN1270958A (zh) | 2000-10-25 |
| EP0668762A4 (de) | 1995-12-20 |
| CN1205184C (zh) | 2005-06-08 |
| AU706985B2 (en) | 1999-07-01 |
| IL107554A0 (en) | 1994-02-27 |
| JPH08503218A (ja) | 1996-04-09 |
| AU2621097A (en) | 1997-09-18 |
| DE69333208D1 (de) | 2003-10-23 |
| CN1065240C (zh) | 2001-05-02 |
| DE69333208T2 (de) | 2004-04-08 |
| JP2006257108A (ja) | 2006-09-28 |
| IL107554A (en) | 2005-03-20 |
| EP0668762B1 (de) | 2003-09-17 |
| WO1994010996A1 (en) | 1994-05-26 |
| EP0668762A1 (de) | 1995-08-30 |
| PT668762E (pt) | 2004-02-27 |
| AU5667094A (en) | 1994-06-08 |
| ES2206465T3 (es) | 2004-05-16 |
| CN1092416A (zh) | 1994-09-21 |
| AU677267B2 (en) | 1997-04-17 |
| CA2147984C (en) | 2006-03-14 |
| DK0668762T3 (da) | 2004-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE249826T1 (de) | Isobutenyl-substituierte taxane und deren pharmazeutische zusammensetzungen | |
| ATA129892A (de) | Pharmazeutische zusammensetzung | |
| DE69101931D1 (de) | Pharmazeutische Zusammensetzung. | |
| DE69432569T2 (de) | Synthese von Taxol und deren Derivate | |
| DE69115263T2 (de) | Pharmazeutische zusammensetzungen. | |
| DE69014351D1 (de) | Pyridincarbonsäureamid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen. | |
| BR9200058A (pt) | Composto e composicao farmaceutica | |
| DE69401335T2 (de) | Gleiskettenspannvorrichtung | |
| ATE101594T1 (de) | Einen zink-komplex enthaltende arzneimittel. | |
| ATE319698T1 (de) | Taxane mit alkyl substituierte seiten-kette und diese enthaltende pharmazeutische zusammenstellungen | |
| DE4294862T1 (de) | Pharmazeutische Komposition | |
| DE69014666T2 (de) | Abgabe von cytotoxischen Mitteln. | |
| ATE220393T1 (de) | Eine heteroethynylen-brücke enthaltende bi- aromatische verbindungen und diese enthaltende pharmazeutische und kosmetische zusammensetzungen | |
| FI955605A (fi) | Aryloivia lääkkeitä | |
| FI921876A0 (fi) | Farmaceutisk komposition inne- haollande diritromycin. | |
| FI934387A0 (fi) | 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner | |
| IL109049A0 (en) | Taxanes having a pyridyl substituted side-chain and pharmaceutical compositions containing them | |
| DE69434010D1 (de) | C7-Taxan-Derivate und diese enthaltende pharmazeutische Zusammenstellungen | |
| ITMI911344A1 (it) | Associazione farmaceutica ad attivita' antineoplastica | |
| ATE307577T1 (de) | Pharmazeutische zusammensetzungen enthaltend neue iso-butenyl-substituierte taxane | |
| BR1100691A (pt) | Composto, e, composição farmacêutica | |
| ITMI921863A1 (it) | Derivati 1, 4-benzotiazinici ad attivita' calcio antagonista | |
| IT8820026A0 (it) | Composizioni farmaceutiche adattivita' antineoplastica. | |
| BR1100486A (pt) | Composto e composição farmacêutica | |
| ITMI922580A0 (it) | Composizione farmaceutica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0668762 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |